Mark William Lowdell, Chief Scientific Officer at Inmune Bio, Inc. (INMB), sold 54,150 shares at $20.02 ($1.1M) on 2021-07-07, disclosed to the SEC on 2021-07-09.
Open-market sale of $1.1M INMB by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 5,850 | $117K | 10.7% |
| 2 | $20.19 | 24,150 | $488K | 44.6% |
| 3 | $20.19 | 24,150 | $488K | 44.6% |
| Total | $20.17 avg | 54,150 | $1.1M | 100% |
| Filing → |
| INMB | SELL | 2021-10-29 | $47K | — | Filing → |
| INMB | SELL | 2021-10-26 | $8K | — | Filing → |
| INMB | BUY | 2019-09-12 | $18K | — | Filing → |